METHOD FOR PREDICTION OF HORMONE-DEPENDENT BREAST CANCER Russian patent published in 2015 - IPC A61B5/00 A61B5/16 

FIELD: medicine.

SUBSTANCE: pre-hospital stage involves patient's questionnaire survey and data specification: age in years, patient's height in cm, patient's weight in kg, length of the menstrual cycle if any, in days: in perimenopause or postmenopause, the number of pregnancies in the past medical history in absolute numbers, the number of therapeutic abortions in absolute numbers, administration of oral contraceptives in the past medical history, prevailing protein nutrition, hormone-dependent tumour. The derived values are introduced into formula. The calculated value is used to consider the tumour hormone-dependent, and the patient is given a hormone therapy until the immunohistochemical findings are obtained and a molecular type of breast cancer is specified; otherwise, the tumour is considered to be hormone-independent, so the hormone therapy is not conducted.

EFFECT: by analysing the medical history data and anthropometric measures with the use of the predictive evaluation model of the hormone-dependent tumour in the patients suffering breast cancer, the method enables specifying the indications for the hormone therapy.

2 tbl, 2 ex